Monoclonal Antibody to Ovalbumin (OVA) 
- UOM
- FOB US$ 167.00 US$ 391.00 US$ 558.00 US$ 1,395.00 US$ 5,580.00
- Quantity
Overview
Properties
- Product No.MAB459Ge21
- Organism SpeciesPan-species (General) Same name, Different species.
- ApplicationsWB
If the antibody is used in flow cytometry, please check FCM antibodies.
Research use only - DownloadInstruction Manual
- CategoryInfection immunityImmune moleculeHematology
- SourceMonoclonal antibody preparation, Host Mouse
- Ig Isotype IgG1 Kappa, Clone Number 3#
- PurificationProtein A + Protein G affinity chromatography
- LabelNone
- Immunogen NPB459Ge01-Native Ovalbumin (OVA)
- Buffer Formulation0.01M PBS, pH7.4, containing 0.05% Proclin-300, 50% glycerol.
- TraitsLiquid, Concentration 1mg/mL
Sign into your account
Share a new citation as an author
Upload your experimental result
Review
Contact us
Please fill in the blank.
-
Packages (Simulation)
-
Packages (Simulation)
-
Western Blot; Sample: Gallus OVA Primary Ab: 0.5µg/ml Mouse Anti-Multi-species OVA Antibody Second Ab: 0.2µg/ml HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody (Catalog: SAA544Mu19) Selected
-
ISO9001: 2008, ISO13485: 2003 Registered
Specifity
The antibody is a mouse monoclonal antibody raised against OVA. It has been selected for its ability to recognize OVA in immunohistochemical staining and western blotting.
Usage
Western blotting: 0.01-2µg/mL;
Optimal working dilutions must be determined by end user.
Storage
Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
Stability
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
Giveaways
Increment services
Citations
- Non-invasive delivery of nanoparticles to hair follicles: A perspective for transcutaneous immunizationPubmed: 23290836
- Alphavbeta6 is required in maintaining the intestinal epithelial barrier functionPubmed:24677750
- Characterization of a novel anti-human lymphocyte activation gene 3 (LAG-3) antibody for cancer immunotherapyPubmed: 31242068
- Double-responsive hyaluronic acid-based prodrugs for efficient tumour targeting34857264